Tuberculosis and Hepatitis

Most healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is an asymptomatic and non-transmissible form of TB. Hepatitis is an inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB) and chronic hepatitis B virus (HBV) infection identified a strong host genetic component to individual variability in disease susceptibility. Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015.

  • Pulmonary/Extra-pulmonary TB
  • Liver syndromes
  • Auto immune hepatitis
  • Infectious Hepatitis
  • Long-Term Hepatitis
  • Hepatitis C Combination
  • Severe Hepatitis
  • Types of Hepatitis
  • Risk Factors
  • Tuberculosis in Children
  • Hepatotoxicity
  • Tuberculosis - Health impact
  • Predominance
  • Causes, Symptoms and Treatments

Related Conference of Tuberculosis and Hepatitis

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

Tuberculosis and Hepatitis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in